Consideration of Viral Resistance for Optimization of Direct Antiviral Therapy of Hepatitis C Virus Genotype 1-Infected Patients

Different highly effective interferon-free treatment options for chronic hepatitis C virus (HCV) infection are currently available. Pre-existence of resistance associated variants (RAVs) to direct antiviral agents (DAAs) reduces sustained virologic response (SVR) rates by 3–53% in hepatitis C virus...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :PLoS One
Главные авторы: Dietz, Julia, Susser, Simone, Berkowski, Caterina, Perner, Dany, Zeuzem, Stefan, Sarrazin, Christoph
Формат: Artigo
Язык:Inglês
Опубликовано: Public Library of Science 2015
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4552686/
https://ncbi.nlm.nih.gov/pubmed/26317755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0134395
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы